IGF-1R/β-catenin signaling axis is implicated in streptozotocin exacerbating bone impairment in ovariectomized rats

References

• Qiu Y, Yang W, Wang Q, et al. Osteoporosis in postmenopausal women in this decade: a bibliometric assessment of current research and future hotspots. Arch Osteoporos 2018;13:121
   PubMed Web of Science ®Google Scholar
• Black DM, Rosen CJ. Clinical practice. Postmenopausal osteoporosis. N Engl J Med 2016;374:254–62
   PubMed Web of Science ®Google Scholar
• Hofbauer LC, Brueck CC, Singh SK, et al. Osteoporosis in patients with diabetes mellitus. J Bone Miner Res 2007;22:1317–28
   PubMed Web of Science ®Google Scholar
• Inzerillo AM, Epstein S. Osteoporosis and diabetes mellitus. Rev Endocr Metab Disord 2004;5:261–8
   PubMed Web of Science ®Google Scholar
• Schwartz AV, Hillier TA, Sellmeyer DE, et al. Older women with diabetes have a higher risk of falls: a prospective study. Diabetes Care 2002;25:1749–54
   PubMed Web of Science ®Google Scholar
• Park YM, Rector RS, Thyfault JP, et al. Effects of ovariectomy and intrinsic aerobic capacity on tissue-specific insulin sensitivity. Am J Physiol Endocrinol Metab 2016;310:E190–9
   PubMed Web of Science ®Google Scholar
• Li B, Wang Y, Liu Y, et al. Altered gene expression involved in insulin signaling pathway in type II diabetic osteoporosis rats model. Endocrine 2013;43:136–46
   PubMed Web of Science ®Google Scholar
• Solomon-Zemler R, Basel-Vanagaite L, Steier D, et al. A novel heterozygous IGF-1 receptor mutation associated with hypoglycemia. Endocr Connect 2017;6:395–403
   PubMed Web of Science ®Google Scholar
• Pelosi P, Lapi E, Cavalli L, et al. Bone status in a patient with insulin-like growth factor-1 receptor deletion syndrome: bone quality and structure evaluation using dual-energy X-ray absorptiometry, peripheral quantitative computed tomography, and quantitative ultrasonography. Front Endocrinol (Lausanne) 2017;8:227
   PubMed Web of Science ®Google Scholar
• Palsgaard J, Emanuelli B, Winnay JN, et al. Cross-talk between insulin and Wnt signaling in preadipocytes: role of Wnt co-receptor low density lipoprotein receptor-related protein-5 (LRP5). J Biol Chem 2012;287:12016–26
   PubMed Web of Science ®Google Scholar
• Rota LM, Wood TL. Crosstalk of the insulin-like growth factor receptor with the Wnt signaling pathway in breast cancer. Front Endocrinol (Lausanne) 2015;6:92
   PubMed Web of Science ®Google Scholar
• Rota LM, Albanito L, Shin ME, et al. IGF1R inhibition in mammary epithelia promotes canonical Wnt signaling and Wnt1-driven tumors. Cancer Res 2014;74:5668–79
   PubMed Web of Science ®Google Scholar
• Zhang Z, Ren H, Shen G, et al. Animal models for glucocorticoid-induced postmenopausal osteoporosis: an updated review. Biomed Pharmacother 2016;84:438–46
   PubMed Web of Science ®Google Scholar
• Gheibi S, Kashfi K, Ghasemi A. A practical guide for induction of type-2 diabetes in rat: incorporating a high-fat diet and streptozotocin. Biomed Pharmacother 2017;95:605–13
   PubMed Web of Science ®Google Scholar
• Chatzigeorgiou A, Halapas A, Kalafatakis K, et al. The use of animal models in the study of diabetes mellitus. In Vivo 2009;23:245–58
   PubMed Web of Science ®Google Scholar
• Napoli N, Chandran M, Pierroz DD, et al. Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol 2017;13:208–19
   PubMed Web of Science ®Google Scholar
• Iitsuka N, Hie M, Tsukamoto I. Zinc supplementation inhibits the increase in osteoclastogenesis and decrease in osteoblastogenesis in streptozotocin-induced diabetic rats. Eur J Pharmacol 2013;714:41–7
   PubMed Web of Science ®Google Scholar
• Ma R, Wang L, Zhao B, et al. Diabetes perturbs bone microarchitecture and bone strength through regulation of sema3A/IGF-1/β-catenin in rats. Cell Physiol Biochem 2017;41:55–66
   PubMedGoogle Scholar
• Burghardt AJ, Issever AS, Schwartz AV, et al. High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2010;95:5045–55
   PubMed Web of Science ®Google Scholar
• Shu A, Yin MT, Stein E, et al. Bone structure and turnover in type 2 diabetes mellitus. Osteoporos Int 2012;23:635–41
   PubMed Web of Science ®Google Scholar
• Cheng Y, Liu S, Zhang X, et al. Expression profiles of IGF-1R gene and polymorphisms of its regulatory regions in different pig breeds. Protein J 2016;35:231–6
   PubMed Web of Science ®Google Scholar
• Iyer S, Ambrogini E, Bartell SM, et al. FOXOs attenuate bone formation by suppressing Wnt signaling. J Clin Invest 2013;123:3409–19
   PubMed Web of Science ®Google Scholar
• Kim IG, Kim SY, Choi SI, et al. Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH + lung cancer stem cells through IGF1R signaling. Oncogene 2014;33:3908–17
   PubMed Web of Science ®Google Scholar
• Leng S, Zhang W, Zheng Y, et al. Glycogen synthase kinase 3 beta mediates high glucose-induced ubiquitination and proteasome degradation of insulin receptor substrate 1. J Endocrinol 2010;206:171–81
   PubMed Web of Science ®Google Scholar
• Geng Y, Ju Y, Ren F, et al. Insulin receptor substrate 1/2 (IRS1/2) regulates Wnt/β-catenin signaling through blocking autophagic degradation of dishevelled2. J Biol Chem 2014;289:11230–41
   PubMed Web of Science ®Google Scholar
• Schlupf J, Steinbeisser H. IGF antagonizes the Wnt/β-Catenin pathway and promotes differentiation of extra-embryonic endoderm. Differentiation 2014;87:209–19
   PubMed Web of Science ®Google Scholar
• Ikeda S, Kishida S, Yamamoto H, et al. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. Embo J 1998;17:1371–84
   PubMed Web of Science ®Google Scholar
• Quevedo C, Alcazar A, Salinas M. Two different signal transduction pathways are implicated in the regulation of initiation factor 2B activity in insulin-like growth factor-1-stimulated neuronal cells. J Biol Chem 2000;275:19192–7
   PubMed Web of Science ®Google Scholar
• Park BC, Kido Y, Accili D. Differential signaling of insulin and IGF-1 receptors to glycogen synthesis in murine hepatocytes. Biochemistry 1999;38:7517–23
   PubMed Web of Science ®Google Scholar
• Tejeda-Munoz N, Robles-Flores M. Glycogen synthase kinase 3 in Wnt signaling pathway and cancer. IUBMB Life 2015;67:914–22
   PubMed Web of Science ®Google Scholar